000			01359naa a2200229uu 4500
001			6979
003			OSt
005			20190211154204.0
008			020917s2005 xx ||||gr |0|| 0 eng d
100	1		_aKAY, Adrian _95460
245	1	0	_aDevolution and drugs : _bthe case for Welsh autonomy
260			_c2002
520	3		_aThe regulation of drug prices is an excellent example of the type of tensions that are emerging in the UK's new system of multi-level governance. Both the benefits and regulatory burden of the Pharmaceutical Price Regulation Scheme (PPRS) are regionally concentrated. However, those regional concentrations are not coterminous. The PPRS as an industrial policy supports jobs primarily in the south east and east of England. However, Wales (along with Scotland and Northern Ireland) bears a relatively greater share of the regulatory burden of the PPRS by virtue of prescribing more medicines. The potential for Welsh autonomy in this are is considered in terms of economic, administrative and political constraints
650		4	_aPharmaceutical Policy _916537
650		4	_aEstado Devolvido _916538
650		4	_aMulti-level Governance _916539
650		4	_aParalallel Importing _916540
773	0	8	_tPolicy & Politics _g30, 2, p. 183-194 _d, 2002 _w
942			_cS
998			_a20020917 _bLucima _cLucimara
998			_a20140709 _b0845^b _ckarina
999			_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c7137 _d7137
041			_aeng